hdm1005
Peptideexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 19, 2024 (NCT06640647)
Timeline
Indications
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07279194 | Phase 3 | Oct 14, 2025 | Fudan University, Hangzhou Zhongmei |
| NCT07109700 | Phase 2 | Apr 30, 2025 | Hangzhou Zhongmei |
| NCT06886126 | Phase 2 | Feb 7, 2025 | Hangzhou Zhongmei, Xiamen University |
| NCT06637020 | Phase 1 | Jun 20, 2024 | Anhui Medical University, Hangzhou Zhongmei |
| NCT06640647 | Phase 1 | Mar 19, 2024 | Anhui Medical University, Hangzhou Zhongmei |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hangzhou Zhongmei | For profit | 5 | 5 | 3 | 2024 |
| Anhui Medical University | Academic/Hospital | 2 | 0 | 1 | 2024 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Xiamen University | Academic/Hospital | 1 | 0 | 1 | 2025 |
4 organizations
Page 1 / 1